Bharath Raghavan

Bharath Raghavan

Auto-generated profile, based on publicly available information

Bharath Raghavan

Affiliations Computational Biomedicine, Institute for Neuroscience and Medicine 9, Forschungszentrum Jülich GmbH, Jülich, Germany, Department of Physics, Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2023 in Journal of Chemical Information and Modeling
Verified
Journal Article
Open access
BRBharath Raghavan
Bharath Raghavan
MPMirko Paulikat
Mirko Paulikat
KAKatya Ahmad
Katya Ahmad
LCLara Callea
Lara Callea
ARAndrea Rizzi
Andrea Rizzi
PCPaolo Carloni
Paolo Carloni
The initial phases of drug discovery - in silico drug design - could benefit from first principle Quantum Mechanics/Molecular Mechanics (QM/MM) molecular dynamics (MD) simulations in explicit solvent, yet many applications are currently limited by the short time scales that this approach can cover. Developing scalable first principle QM/MM MD interfaces fully exploiting current exascale machines - so far an unmet and crucial goal - will help overcome this problem, opening the way to the study of the thermodynamics and kinetics of ligand binding to protein with first principle accuracy. Here, taking two relevant case studies involving the interactions of ligands with rather large enzymes, we showcase the use of our recently developed massively scalable Multiscale Modeling in Computational Chemistry (MiMiC) QM/MM framework (currently using DFT to describe the QM region) to investigate reactions and ligand binding in enzymes of pharmacological relevance. We also demonstrate for the first time strong scaling of MiMiC-QM/MM MD simulations with parallel efficiency of ∼70% up to >80,000 cores. Thus, among many others, the MiMiC interface represents a promising candidate toward exascale applications by combining machine learning with statistical mechanics based algorithms tailored for exascale supercomputers.

12 January 2017 in The Journal of Physical Chemistry C
Verified
Journal Article
Closed access
BRBharath Raghavan
Bharath Raghavan
TGTribikram Gupta
Tribikram Gupta

11 July 2024 in The Journal of Chemical Physics
Verified
Journal Article
Closed access
PDF file
AAAndrej Antalík
Andrej Antalík
ALAndrea Levy
Andrea Levy
SKSonata Kvedaravičiūtė
Sonata Kvedaravičiūtė
SJSophia K. Johnson
Sophia K. Johnson
DCDavid Carrasco-Busturia
David Carrasco-Busturia
JOJógvan Magnus Haugaard Olsen
Jógvan Magnus Haugaard Olsen
MiMiC is a framework for performing multiscale simulations in which loosely coupled external programs describe individual subsystems at different resolutions and levels of theory. To make it highly efficient and flexible, we adopt an interoperable approach based on a multiple-program multiple-data (MPMD) paradigm, serving as an intermediary responsible for fast data exchange and interactions between the subsystems. The main goal of MiMiC is to avoid interfering with the underlying parallelization of the external programs, including the operability on hybrid architectures (e.g., CPU/GPU), and keep their setup and execution as close as possible to the original. At the moment, MiMiC offers an efficient implementation of electrostatic embedding quantum mechanics/molecular mechanics (QM/MM) that has demonstrated unprecedented parallel scaling in simulations of large biomolecules using CPMD and GROMACS as QM and MM engines, respectively. However, as it is designed for high flexibility with general multiscale models in mind, it can be straightforwardly extended beyond QM/MM. In this article, we illustrate the software design and the features of the framework, which make it a compelling choice for multiscale simulations in the upcoming era of exascale high-performance computing.

22 February 2023 in Journal of Chemical Information and Modeling
Verified
Journal Article
Open access
BRBharath Raghavan
Bharath Raghavan
FSFlorian K. Schackert
Florian K. Schackert
ALAndrea Levy
Andrea Levy
SJSophia K. Johnson
Sophia K. Johnson
EIEmiliano Ippoliti
Emiliano Ippoliti
PCPaolo Carloni
Paolo Carloni
MiMiC is a highly flexible, extremely scalable multiscale modeling framework. It couples the CPMD (quantum mechanics, QM) and GROMACS (molecular mechanics, MM) codes. The code requires preparing separate input files for the two programs with a selection of the QM region. This can be a tedious procedure prone to human error, especially when dealing with large QM regions. Here, we present MiMiCPy, a user-friendly tool that automatizes the preparation of MiMiC input files. It is written in Python 3 with an object-oriented approach. The main subcommand PrepQM can be used to generate MiMiC inputs directly from the command line or through a PyMOL/VMD plugin for visually selecting the QM region. Many other subcommands are also provided for debugging and fixing MiMiC input files. MiMiCPy is designed with a modular structure that allows seamless extensions to new program formats depending on the requirements of MiMiC.

26 June 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
BRBharath Raghavan
Bharath Raghavan
MVMarco De Vivo
Marco De Vivo
PCPaolo Carloni
Paolo Carloni
R132H IDH1 is an important therapeutic target for a variety of brain cancers, yet drug leads and radiotracers which selectively bind only to the mutant over the wild type are so far lacking. Here we have predicted the structural determinants of the Michaelis complex of this mutant using a QM/MM MD-based protocol. It shows some important differences with the X-ray structure, from the metal coordination to the positioning of key residues at the active site. In particular, one lysine residue (K212) emerges as a mostly likely proton donor in the key proton-transfer step of the R132H IDH1 catalytic reaction. Intriguingly, the same residue in its deprotonated state is likely to be involved in the reaction catalyzed by the wild-type enzyme (though the mechanisms are different). Our QM/MM protocol could also be used for other metal-based enzymes, which cannot be modelled easily by force field-based MD, like in this case.

14 August 2024 in ChemRxiv
Verified
Preprint
Open access
PDF file
BRBharath Raghavan
Bharath Raghavan
MVMarco De Vivo
Marco De Vivo
PCPaolo Carloni
Paolo Carloni
R132H IDH1 is an important therapeutic target for a variety of brain cancers, yet drug leads and radiotracers which selectively bind only to the mutant over the wild type are so far lacking. Here we have predicted the structural determinants of the Michaelis complex of this mutant using a QM/MM MD-based protocol. It shows some important differences with the X-ray structure, from the metal coordination to the positioning of key residues at the active site. In particular, one lysine residue at the active site emerges as a mostly likely proton donor in the R132H IDH1 catalytic reaction. Intriguingly, the same residue in its deprotonated state is likely to be involved in the reaction catalyzed by the wild-type enzyme. Our QM/MM protocol could also be used for other metal-based enzymes, which cannot be modeled easily by force field-based MD, like in this case.